Letters to the Editor

Quantitative PCR-based chimerism in bone marrow or peripheral blood to predict acute myeloid leukemia relapse in high-risk patients: results from the KIM-PB prospective study

Unit of Immunogenetics, Leukemia Genomics and Immunobiology, IRCCS San Raffaele Scientific Institute, Milano
Unit of Immunogenetics, Leukemia Genomics and Immunobiology, IRCCS San Raffaele Scientific Institute, Milano
Unit of Immunogenetics, Leukemia Genomics and Immunobiology, IRCCS San Raffaele Scientific Institute, Milano, Italy; Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano
Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano
GenDx, Utrecht
Unit of Immunogenetics, Leukemia Genomics and Immunobiology, IRCCS San Raffaele Scientific Institute, Milano
Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano
Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano
Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano
Vita-Salute San Raffaele University, Milano
HLA and Chimerism Laboratory, IRCCS San Raffaele Scientific Institute, Milano
GenDx, Utrecht
Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano
Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano
Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy; Vita-Salute San Raffaele University, Milano
Unit of Immunogenetics, Leukemia Genomics and Immunobiology, IRCCS San Raffaele Scientific Institute, Milano, Italy; Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano
Haematologica Early view Sep 10, 2020 https://doi.org/10.3324/haematol.2019.238543